跳至主要内容
临床试验/NCT05521113
NCT05521113已完成不适用

Feasibility of Home-based Pulmonary Rehabilitation With Remote Monitoring in Pulmonary Arterial Hypertension

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2022年9月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
14
试验地点
1
主要终点
Adverse Events

研究概览

简要总结

The purpose of this study is to test new technology and health coaching aimed to help people with PAH become more physically active in their daily lives.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of PAH, confirmed by right heart catheterization (mean pulmonary artery pressure of 20 mmHg or greater, pulmonary vascular resistance of 3.0 Woods units or greater, Pulmonary capillary wedge pressure of 15 mmHg or lower).
  • On PAH-specific therapy which is at stable dosing (i.e., not currently titrating therapy).
  • NYHA class II-III symptoms.
  • Able to complete a six-minute walk test.

排除标准

  • Patients experiencing syncope or exertional syncope.
  • Patients not experiencing exertional dyspnea.
  • Inability to walk.
  • Patients currently in pulmonary rehab or having completed pulmonary rehab within three months (unlikely to improve).

结局指标

主要结局

Adverse Events

时间窗: 12 weeks

Number of adverse events attributed to home-based pulmonary rehabilitation

次要结局

  • Change in EmPHasis-10 Quality of Life Survey(Baseline, 3 months)
  • Change in daily physical activity(Baseline, 3 months)
  • Change in exercise capacity(Baseline, 3 months)
  • Change in PAH-SYMPACT domain scores Quality of Life(Baseline, 3 months)
  • Change in self-management abilities(Baseline, 3 months)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hilary M. DuBrock, MD

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验